TruBridge Names Merideth Wilson as Financial Health General Manager
TruBridge (NASDAQ: TBRG) has appointed Merideth Wilson as the new Financial Health General Manager. The Financial Health unit, representing 65% of company revenue with over 2,000 employees, focuses on Revenue Cycle Management (RCM) technology and services for acute and ambulatory settings.
Wilson brings 25 years of healthcare technology leadership experience, including 20 years at Experian, where she most recently served as Executive Vice President and General Manager of Experian Employer Services. In her previous role as Senior VP of Revenue Cycle Solutions, she managed approximately $235 million in annual revenue and led initiatives to offshore 50% of the outsourcing team.
This appointment aligns with TruBridge's recent portfolio consolidation into two primary business units: Financial Health under Wilson and Patient Care under David Harse, who joined from Cerner two years ago to lead the EHR and patient engagement offerings.
TruBridge (NASDAQ: TBRG) ha nominato Merideth Wilson come nuovo Direttore Generale della Salute Finanziaria. L'unità Salute Finanziaria, che rappresenta il 65% del fatturato dell'azienda con oltre 2.000 dipendenti, si concentra sulla tecnologia e i servizi di gestione del ciclo di fatturazione (RCM) per le strutture acute e ambulatoriali.
Wilson porta con sé 25 anni di esperienza nella leadership tecnologica nel settore sanitario, inclusi 20 anni presso Experian, dove ha ricoperto l’ultimo ruolo come Vicepresidente Esecutivo e Direttore Generale dei Servizi per i Datori di Lavoro di Experian. Nel suo precedente ruolo come VP Senior delle Soluzioni per il Ciclo di Fatturazione, ha gestito circa 235 milioni di dollari di fatturato annuale e ha guidato iniziative per delocalizzare il 50% del team di outsourcing.
Questa nomina si allinea con la recente consolidazione del portafoglio di TruBridge in due principali unità operative: Salute Finanziaria sotto la direzione di Wilson e Cura del Paziente sotto David Harse, che è entrato in azienda da Cerner due anni fa per guidare le offerte di EHR e di coinvolgimento dei pazienti.
TruBridge (NASDAQ: TBRG) ha nombrado a Merideth Wilson como nueva Directora General de Salud Financiera. La unidad de Salud Financiera, que representa el 65% de los ingresos de la empresa con más de 2,000 empleados, se centra en la tecnología y servicios de gestión del ciclo de ingresos (RCM) para entornos agudos y ambulatorios.
Wilson aporta 25 años de experiencia en liderazgo de tecnología de salud, incluidos 20 años en Experian, donde ocupó los últimos puestos como Vicepresidenta Ejecutiva y Directora General de Servicios para Empleadores de Experian. En su rol anterior como VP Senior de Soluciones de Ciclo de Ingresos, gestionó aproximadamente 235 millones de dólares en ingresos anuales y lideró iniciativas para externalizar el 50% del equipo de outsourcing.
Esta designación se alinea con la reciente consolidación del portafolio de TruBridge en dos unidades de negocio principales: Salud Financiera bajo la dirección de Wilson y Cuidado del Paciente bajo David Harse, quien se unió desde Cerner hace dos años para liderar las ofertas de EHR y de participación del paciente.
TruBridge (NASDAQ: TBRG)는 Merideth Wilson을 새로운 재무 건강 총괄 관리자로 임명했습니다. 재무 건강 부서는 2,000명 이상의 직원을 보유하고 있으며 회사 수익의 65%를 차지하며 급성 및 외래 환경을 위한 수익 주기 관리(RCM) 기술 및 서비스에 집중하고 있습니다.
Wilson은 의료 기술 분야에서 25년의 리더십 경험을 가지고 있으며, 그중 20년을 Experian에서 보냈습니다. 최근에는 Experian 고용주 서비스의 부사장이자 총괄 관리자로 근무했으며, 이전에는 수익 주기 솔루션의 수석 부사장으로서 연간 약 2억 3천 5백만 달러의 수익을 관리하고 아웃소싱 팀의 50%를 해외로 이전하는 이니셔티브를 이끌었습니다.
이번 임명은 TruBridge의 최근 포트폴리오 통합과 일치하며, 두 개의 주요 사업 부서인 Wilson 이하의 재무 건강 부서와 Cerner에서 두 번째로 EHR 및 환자 참여 솔루션을 이끌기 위해 합류한 David Harse 아래의 환자 관리 부서로 구성됩니다.
TruBridge (NASDAQ: TBRG) a nommé Merideth Wilson comme nouvelle Directrice Générale de la Santé Financière. L'unité Santé Financière, représentant 65 % du chiffre d'affaires de l'entreprise avec plus de 2 000 employés, se concentre sur la technologie et les services de gestion du cycle de revenus (RCM) pour les établissements aigus et ambulatoires.
Wilson a 25 ans d'expérience en leadership dans la technologie de la santé, dont 20 ans chez Experian, où elle a occupé récemment le poste de Vice-Présidente Exécutive et Directrice Générale des Services aux Employeurs d'Experian. Dans son rôle précédent de Vice-Présidente Senior des Solutions de Cycle de Revenus, elle gérait environ 235 millions de dollars de revenus annuels et a dirigé des initiatives pour externaliser 50 % de l'équipe d'externalisation.
Cette nomination s'inscrit dans le cadre de la récente consolidation du portefeuille de TruBridge en deux unités commerciales principales : la Santé Financière sous la direction de Wilson et les Soins aux Patients sous David Harse, qui a rejoint Cerner il y a deux ans pour diriger les offres EHR et d'engagement des patients.
TruBridge (NASDAQ: TBRG) hat Merideth Wilson zur neuen General Managerin für Finanzgesundheit ernannt. Die Einheit Finanzgesundheit, die 65 % des Unternehmensumsatzes mit über 2.000 Mitarbeitern ausmacht, konzentriert sich auf Technologien und Dienstleistungen im Bereich des Revenue Cycle Management (RCM) für akute und ambulante Einrichtungen.
Wilson bringt 25 Jahre Erfahrung in der Führung von Gesundheitstechnologien mit, darunter 20 Jahre bei Experian, wo sie zuletzt als Executive Vice President und General Manager von Experian Employer Services tätig war. In ihrer vorherigen Rolle als Senior VP für Revenue Cycle Solutions verwaltete sie jährlich etwa 235 Millionen Dollar Umsatz und leitete Initiativen zur Auslagerung von 50 % des Outsourcing-Teams.
Diese Ernennung steht im Einklang mit der kürzlichen Portfolio-Konsolidierung von TruBridge in zwei Hauptgeschäftseinheiten: Finanzgesundheit unter Wilson und Patientenversorgung unter David Harse, der vor zwei Jahren von Cerner kam, um die EHR- und Patientenengagement-Angebote zu leiten.
- Financial Health unit represents significant 65% of company revenue
- Strategic hire brings 25 years of healthcare technology leadership experience
- New GM has track record of successful cost reduction through offshoring initiatives
- Demonstrated experience managing $235M annual revenue at previous position
- None.
Brings 25 Years of Healthcare Technology Leadership to Company
Wilson joins TruBridge with 25 years of healthcare technology leadership experience, including 20 years with Experian, where she most recently served as Executive Vice President and General Manager, Experian Employer Services. In this role, she was responsible for driving strategic, financial and operational objectives for a newly formed business unit with a focus on margin growth. Prior to this, she served as Chief Operations Officer of Experian Health. In her previous position as Senior Vice President and General Manager of Revenue Cycle Solutions, she had responsibility for approximately
Wilson has an MBA from the Eugene W. Stetson School of Business & Economics at Mercer University and a BBA, Business Administration, Management, General from Baylor University.
Commenting on the announcement, Chris Fowler, president and chief executive officer of TruBridge, Inc., stated, “We are delighted to have Merideth Wilson join TruBridge in this important senior leadership role. She is an accomplished healthcare technology executive with extensive experience driving RCM technology solutions and services and brings valuable insight for executing a global workforce strategy. She is uniquely qualified to lead Financial Health as we continue to capitalize on the growing demand for innovative RCM solutions and extend our market reach into the acute and ambulatory markets.
“This addition to our senior leadership team aligns with the consolidation of our diverse portfolio of solutions earlier this year and elevates the two primary business units, providing the respective leaders with greater autonomy and responsibility to achieve our goals and vision. We are fortunate to have two accomplished General Managers, with Merideth Wilson now leading Financial Health and 20-year industry veteran David Harse, who joined us from Cerner two years ago, continuing to lead the Patient Care business unit, which includes our electronic healthcare record (EHR) and patient engagement product offerings. We are confident both David and Merideth have the right industry knowledge and a proven ability to drive transformational business growth and achieve our objectives. Together, we look forward to the opportunities ahead for TruBridge as we pursue a strategy that supports more community healthcare providers and creates value for our shareholders,” added Fowler.
About TruBridge
We are a trusted partner to more than 1,500 healthcare organizations with a broad range of technology-first solutions that address the unique needs and challenges of diverse communities, promoting equitable access to quality care and fostering positive outcomes. TruBridge has over four decades of experience in connecting providers, patients and communities with innovative data-driven solutions that create real value by supporting both the financial and clinical side of healthcare delivery. Our industry leading HFMA Peer Reviewed® suite of revenue cycle management (RCM) offerings combine unparalleled visibility and transparency to enhance productivity and support the financial health of healthcare organizations across all care settings. We support efficient patient care with electronic health record (EHR) product offerings that successfully integrate data between care settings. Above all, we believe in the power of community and encourage collaboration, connection, and empowerment with our customers. We clear the way for care. For more information, please visit www.trubridge.com.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified generally by the use of forward-looking terminology and words such as ”expects,” “anticipates,” “estimates,” “believes,” “predicts,” “intends,” “plans,” “potential,” “may,” “continue,” “should,” “will” and words of comparable meaning. Without limiting the generality of the preceding statement, all statements in this press release relating to the Company’s ability to execute on its strategy, including the shift to the RCM business, and to enhance value for the Company’s shareholders are forward-looking statements. We caution investors that any such forward-looking statements are only predictions and are not guarantees of future performance. Certain risks, uncertainties and other factors may cause actual results to differ materially from those projected in the forward-looking statements. Such factors may include: saturation of our target market and hospital consolidations; unfavorable economic or market conditions that may cause a decline in spending for information technology and services; significant legislative and regulatory uncertainty in the healthcare industry; exposure to liability for failure to comply with regulatory requirements; pandemics and other public health crises and related economic disruptions; transition to a subscription-based recurring revenue model and modernization of our technology; competition with companies that have greater financial, technical and marketing resources than we have; potential future acquisitions that may be expensive, time consuming, and subject to other inherent risks; our ability to attract and retain qualified client service and support personnel; disruption from periodic restructuring of our sales force; potential delay in the development of markets for our RCM service offering; potential inability to properly manage growth in new markets we may enter; potential disruption of our business due to our ongoing implementation of a new enterprise resource planning software solution; exposure to numerous and often conflicting laws, regulations, policies, standards or other requirements through our international business activities; potential litigation against us; our reliance on an international workforce which exposes us to various business disruptions; our utilization of artificial intelligence, which could expose us to liability or adversely affect our business if we cannot compete effectively with others using artificial intelligence; potential failure to develop new products or enhance current products that keep pace with market demands; failure of our products to function properly resulting in claims for medical and other losses; breaches of security and viruses in our systems resulting in customer claims against us and harm to our reputation; failure to maintain customer satisfaction through new product releases free of undetected errors or problems; failure to convince customers to migrate to current or future releases of our products; failure to maintain our margins and service rates; increase in the percentage of total revenues represented by service revenues, which have lower gross margins; exposure to liability in the event we provide inaccurate claims data to payors; exposure to liability claims arising out of the licensing of our software and provision of services; dependence on licenses of rights, products and services from third parties; misappropriation of our intellectual property rights and potential intellectual property claims and litigation against us; interruptions in our power supply and/or telecommunications capabilities, including those caused by natural disaster; potential inability to secure additional financing on favorable terms to meet our future capital needs; our substantial indebtedness, and our ability to incur additional indebtedness in the future; pressures on cash flow to service our outstanding debt; restrictive terms of our credit agreement on our current and future operations; changes in and interpretations of financial accounting matters that govern the measurement of our performance; significant charges to earnings if our goodwill or intangible assets become impaired; fluctuations in quarterly financial performance due to, among other factors, timing of customer installations; volatility in our stock price; failure to maintain effective internal control over financial reporting; inherent limitations in our internal control over financial reporting; vulnerability to significant damage from natural disasters; market risks related to interest rate changes; potential material adverse effects due to macroeconomic conditions, including bank failures or changes in related regulation; and other risk factors described from time to time in our public releases and reports filed with the Securities and Exchange Commission, including, but not limited to, our most recent Annual Report on Form 10-K and our Quarterly Report on Form 10-Q for the quarter ended September 30, 2024. We also caution investors that the forward-looking information described herein represents our outlook only as of this date, and we undertake no obligation to update or revise any forward-looking statements to reflect events or developments after the date of this press release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250102146182/en/
Tracey Schroeder
Chief Marketing Officer
Tracey.Schroeder@trubridge.com
Source: TruBridge, Inc.
FAQ
What percentage of TruBridge (TBRG) revenue comes from its Financial Health unit?
How many employees work in TruBridge's (TBRG) Financial Health division?
What experience does Merideth Wilson bring to TruBridge (TBRG)?
What are the two main business units of TruBridge (TBRG) after its recent consolidation?
What services does TruBridge's (TBRG) Financial Health unit provide?
